Related Experiment Video
Updated: Jul 15, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Evaluation of underlying risk as a source of heterogeneity in meta-analyses: a simulation study of Bayesian and
Ian Dohoo1, Henrik Stryhn, Javier Sanchez
1Department of Health Management, University of Prince Edward Island, Charlottetown, PEI, Canada. dohoo@upei.ca
Abstract:
Evaluation of important causes of heterogeneity among study results is an important component of any meta-analysis. For factors which can be measured (e.g. population characteristics, indicators of study quality), standard methods such as meta-regression can be used for this evaluation. The underlying risk (i.e. risk of outcome in the control population) can be viewed as a summary of the effects of unmeasured population characteristics so it is a logical candidate for evaluation as a source of heterogeneity. Unfortunately, because of its relationship with the study outcome (odds ratio or relative risk), standard methods should not be used for evaluating underlying risk as a cause of heterogeneity. Three models with different sets of underlying assumptions were evaluated in a simulation study to determine how well they performed in assessing the role of underlying risk as a source of heterogeneity. All models were fit using both Bayesian and frequentist (maximum likelihood random slopes models) estimation procedures and the results compared. Two of the models produced good results (i.e. minimal evidence of bias in parameter estimates), while the third clearly produced biased estimates of some parameters. In general, the Bayesian and frequentist approaches produced similar results. In situations in which the number of studies in a meta-analysis is small ( approximately 10), the maximum likelihood (frequentist) approach was preferable. While the bias induced by heterogeneity associated with underlying risk was generally not large, use of one of the approaches described in this paper will produce better estimates of treatment effect in situations where there is substantial heterogeneity between studies. A model based on the assumption that the number of positive events in each of the treatment and control groups are binomially distributed (Model 1) is the recommended approach.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Assumptions of Survival Analysis
Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance, comparing...
Parametric Survival Analysis: Weibull and Exponential Methods
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
